The causal relationship between insulin resistance and Alzheimer’s disease (AD) may involve multiple mechanisms beyond amyloid-beta accumulation and tau hyperphosphorylation, which are common pathological features of AD. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.